Pulmonary catabolism of interferon-gamma evaluated by lung perfusion of both normal and smoke-exposed rats

J Interferon Cytokine Res. 1995 Mar;15(3):225-30. doi: 10.1089/jir.1995.15.225.

Abstract

The role of the lungs in the catabolism of rat recombinant interferon-gamma, either in normal rats or in rats subjected to an acute cigarette smoking episode, was evaluated using an isolated and perfused lung preparation. After administration of interferon-gamma into the lung perfusion medium, there was no clearance of the cytokine in either control or smoke-exposed rat lungs, and only 0.1 +/- 0.2% of the total dose was recovered in the bronchoalveolar lavage fluid. When the same amount of interferon-gamma was instilled into the bronchial alveolar tree, concentrations of the cytokine in the perfusate increased progressively so that after 3 h up to 71.2 +/- 4.3 and 62 +/- 5.7% of the administered dose, as measured by ELISA test, had been transferred from the bronchial lumen to the perfusion medium of either control or smoke-exposed rat lungs, respectively, the latter values being significantly lower (p < or = 0.05) than those obtained in control lungs. Moreover, total recoveries of interferon-gamma evaluated in smoke-exposed rat lungs (78.4 +/- 8.6%) were also significantly lower than those observed in control rat lungs (91.4 +/- 11.8%). Biologic activity evaluations on the same samples gave values significantly lower than those obtained using ELISA, indicating a partial loss of biologic activity during transalveolar transit. In conclusion, it appears that the transfer of interferon-gamma is almost exclusively unidirectional from the alveolar space to the plasmatic pool, with partial degradation during transalveolar passage.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Capillary Permeability / drug effects
  • Carboxyhemoglobin / metabolism
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacokinetics
  • Kinetics
  • Lung / metabolism*
  • Male
  • Perfusion
  • Rats
  • Rats, Wistar
  • Recombinant Proteins
  • Smoke / adverse effects*

Substances

  • Recombinant Proteins
  • Smoke
  • Interferon-gamma
  • Carboxyhemoglobin